Quality · Access · Hope
Countries

🇸🇦 Country Profile

Saudi Arabia

Fast-growing pharmaceutical trade with Saudi Arabia

🇸🇦 $186M
All data from DGCIS India export records (fiscal year, April–March).
$186M
Scale
Saudi Arabia's healthcare system receives $186M in Indian pharmaceutical products each year — affordable, quality medicine.
67%
Medicine
Primarily medicines (67%), supplemented by medicine ingredients and surgical & hospital supplies.
4.2×
Trajectory
One of the faster-growing relationships — India's pharmaceutical supply to Saudi Arabia has expanded 4.2× over the decade.
Context
Part of India's pharmaceutical supply network across Middle East.
✦
Impact
Indian pharmaceutical companies have both exported to and invested directly in Saudi Arabia — building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharma categories from DGCIS (487-code basket)

Category Mix — FY 2025–26 DGCIS
Medicines $125M (67.2%) Medicine Ingredients $43.4M (23.3%) Surgical & Hospital Supplies $10.4M (5.6%) Traditional & Herbal $4.5M (2.4%) Vaccines $2.8M (1.5%)
Top Products — FY 2025–26 DGCIS
Indian Pharma Investment in Saudi Arabia Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Saudi Arabia: $1.3M across 3 filings (2016-2022).